{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:18:26Z","timestamp":1788445106141,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,7,15]],"date-time":"2027-07-15T00:00:00Z","timestamp":1815609600000},"content-version":"am","delay-in-days":287,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mathematical Biosciences"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.mbs.2026.109764","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:17:38Z","timestamp":1783603058000},"page":"109764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Optimal melanoma treatment protocols: A bilinear control model"],"prefix":"10.1016","volume":"400","author":[{"given":"Anthony","family":"Zamora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia L.","family":"Komarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souvik","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10151","key":"10.1016\/j.mbs.2026.109764_bib0001","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(18)31559-9","article-title":"Melanoma","volume":"392","author":"Schadendorf","year":"2018","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.mbs.2026.109764_bib0002","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1056\/NEJMoa1112302","article-title":"Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib","volume":"366","author":"Sosman","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"26","key":"10.1016\/j.mbs.2026.109764_bib0003","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"7326","key":"10.1016\/j.mbs.2026.109764_bib0004","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nature09626","article-title":"Melanomas acquire resistance to B-RAF (V600E) inhibition by RTK or N-RAS upregulation","volume":"468","author":"Nazarian","year":"2010","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.mbs.2026.109764_bib0005","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/ncomms1727","article-title":"Melanoma whole-exome sequencing identifies V600E B-RAF amplification-mediated acquired B-RAF inhibitor resistance","volume":"3","author":"Shi","year":"2012","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.mbs.2026.109764_bib0006","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrc3760","article-title":"Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond","volume":"14","author":"Holderfield","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"7436","key":"10.1016\/j.mbs.2026.109764_bib0007","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature11814","article-title":"Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance","volume":"494","author":"Thakur","year":"2013","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.mbs.2026.109764_bib0008","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ccell.2014.11.018","article-title":"Tunable-combinatorial mechanisms of acquired resistance limit the efficacy of BRAF\/MEK cotargeting but result in melanoma drug addiction","volume":"27","author":"Moriceau","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.mbs.2026.109764_bib0009","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejca.2016.07.024","article-title":"Phase i trials in melanoma: a framework to translate preclinical findings to the clinic","volume":"67","author":"Kim","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.mbs.2026.109764_bib0010","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ebiom.2019.09.023","article-title":"Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanoma","volume":"48","author":"Smalley","year":"2019","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.mbs.2026.109764_bib0011","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3390\/cancers13040823","article-title":"Adaptive therapy for metastatic melanoma: predictions from patient calibrated mathematical models","volume":"13","author":"Kim","year":"2021","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.mbs.2026.109764_bib0012","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1158\/0008-5472.CAN-19-2669","article-title":"Towards multidrug adaptive therapy","volume":"80","author":"West","year":"2020","journal-title":"Cancer Res."},{"issue":"1925","key":"10.1016\/j.mbs.2026.109764_bib0013","doi-asserted-by":"crossref","DOI":"10.1098\/rspb.2019.2454","article-title":"Optimizing adaptive cancer therapy: dynamic programming and evolutionary game theory","volume":"287","author":"Gluzman","year":"2020","journal-title":"Proc. R. Soc. B"},{"key":"10.1016\/j.mbs.2026.109764_bib0014","doi-asserted-by":"crossref","unstructured":"J. West, J. Gallaher, M. Strobl, M. Robertson-Tessi, A.R.A. Anderson, The fundamentals of evolutionary therapy in cancer, Cancer Syst. Biol. Transl. Math. Oncol. (2023) 389\u2013400.","DOI":"10.1093\/med\/9780192867636.003.0038"},{"issue":"1","key":"10.1016\/j.mbs.2026.109764_bib0015","doi-asserted-by":"crossref","first-page":"905","DOI":"10.15252\/msb.20166796","article-title":"Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly dividing de-differentiated state","volume":"13","author":"Fallahi-Sichani","year":"2017","journal-title":"Mol. Syst. Biol."},{"issue":"10","key":"10.1016\/j.mbs.2026.109764_bib0016","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/s41591-020-1060-8","article-title":"Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trial","volume":"26","author":"Algazi","year":"2020","journal-title":"Nat. Med."},{"issue":"15","key":"10.1016\/j.mbs.2026.109764_bib0017","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.3390\/math11153289","article-title":"Optimal melanoma treatment protocols for a bilinear control model","volume":"11","author":"Khailov","year":"2023","journal-title":"Mathematics"},{"key":"10.1016\/j.mbs.2026.109764_bib0018","doi-asserted-by":"crossref","DOI":"10.1201\/9781003152620","article-title":"The Sequential Quadratic Hamiltonian Method: Solving Optimal Control Problems","author":"Borz\u00ec","year":"2023"},{"key":"10.1016\/j.mbs.2026.109764_bib0019","series-title":"The Mathematical Theory of Optimal Processes","author":"Pontryagin","year":"1962"},{"issue":"3","key":"10.1016\/j.mbs.2026.109764_bib0020","doi-asserted-by":"crossref","DOI":"10.1002\/num.70103","article-title":"Optimal control of the viscous wave equation via the pontryagin maximum principle","volume":"42","author":"Borz\u00ec","year":"2026","journal-title":"Numer. Methods Part. Differ. Equ."},{"key":"10.1016\/j.mbs.2026.109764_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.cam.2024.116065","article-title":"A high contrast and resolution reconstruction algorithm in quantitative photoacoustic tomography","volume":"451","author":"Dey","year":"2024","journal-title":"J. Comput. Appl. Math."},{"key":"10.1016\/j.mbs.2026.109764_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1109\/TCI.2021.3137146","article-title":"A new nonlinear sparse optimization framework in ultrasound-modulated optical tomography","volume":"8","author":"Roy","year":"2022","journal-title":"IEEE Trans. Comput. Imaging"},{"key":"10.1016\/j.mbs.2026.109764_bib0023","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6420\/ae1bcd","article-title":"A PINN-driven game-theoretic framework in limited data photoacoustic tomography","author":"Roy","year":"2025","journal-title":"Inverse Probl."},{"issue":"11","key":"10.1016\/j.mbs.2026.109764_bib0024","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1158\/0008-5472.CAN-08-3658","article-title":"Adaptive therapy","volume":"69","author":"Gatenby","year":"2009","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.mbs.2026.109764_bib0025","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1038\/s41467-017-01968-5","article-title":"Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer","volume":"8","author":"Zhang","year":"2017","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.mbs.2026.109764_bib0026","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s43856-022-00110-x","article-title":"Spatial structure impacts adaptive therapy by shaping intra-tumoral competition","volume":"2","author":"Strobl","year":"2022","journal-title":"Commun. Med."},{"issue":"1","key":"10.1016\/j.mbs.2026.109764_bib0027","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1534\/genetics.120.303422","article-title":"Mutant evolution in spatially structured and fragmented expanding populations","volume":"216","author":"Wodarz","year":"2020","journal-title":"Genetics"},{"issue":"9","key":"10.1016\/j.mbs.2026.109764_bib0028","doi-asserted-by":"crossref","DOI":"10.1093\/pnasnexus\/pgaf271","article-title":"Efficient mathematical methodology to determine multistep mutant burden in spatially growing cell populations","volume":"4","author":"Komarova","year":"2025","journal-title":"PNAS Nexus"},{"issue":"3","key":"10.1016\/j.mbs.2026.109764_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004142","article-title":"Spatial heterogeneity in drug concentrations can facilitate the emergence of resistance to cancer therapy","volume":"11","author":"Fu","year":"2015","journal-title":"PLoS Comput. Biol."},{"issue":"7","key":"10.1016\/j.mbs.2026.109764_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1010254","article-title":"Simulations of tumor growth and response to immunotherapy by coupling a spatial agent-based model with a whole-patient quantitative systems pharmacology model","volume":"18","author":"Ruiz-Martinez","year":"2022","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.mbs.2026.109764_bib0031","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.mbs.2013.12.007","article-title":"On assessing quality of therapy in non-linear distributed mathematical models for brain tumor growth dynamics","volume":"248","author":"Bratus","year":"2014","journal-title":"Math. Biosci."},{"issue":"16","key":"10.1016\/j.mbs.2026.109764_bib0032","doi-asserted-by":"crossref","first-page":"9371","DOI":"10.1002\/mma.8311","article-title":"Control of tumor growth modeled by system of PDE, numerical analysis of optimality conditions","volume":"45","author":"Nowakowski","year":"2022","journal-title":"Math. Methods Appl. Sci."},{"issue":"9","key":"10.1016\/j.mbs.2026.109764_bib0033","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1080\/02331934.2023.2232141","article-title":"Optimal control for a nonlinear stochastic PDE model of cancer growth","volume":"73","author":"Esmaili","year":"2024","journal-title":"Optimization"},{"key":"10.1016\/j.mbs.2026.109764_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.cnsns.2025.108677","article-title":"Optimal control for a reaction\u2013diffusion model with tumor-immune interactions","volume":"145","author":"Li","year":"2025","journal-title":"Commun. Nonlinear Sci. Numer. Simul."},{"key":"10.1016\/j.mbs.2026.109764_bib0035","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-026-41810-x","article-title":"Fractional spatiotemporal Hahnfeldt tumor model with convergence analysis and optimal control","volume":"16","author":"Can","year":"2026","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.mbs.2026.109764_bib0036","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.tree.2013.05.020","article-title":"Tumor growth dynamics: insights into evolutionary processes","volume":"28","author":"Rodriguez-Brenes","year":"2013","journal-title":"Trends Ecol. Evol."}],"container-title":["Mathematical Biosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025556426001549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025556426001549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:57:58Z","timestamp":1788443878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025556426001549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":36,"alternative-id":["S0025556426001549"],"URL":"https:\/\/doi.org\/10.1016\/j.mbs.2026.109764","relation":{},"ISSN":["0025-5564"],"issn-type":[{"value":"0025-5564","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimal melanoma treatment protocols: A bilinear control model","name":"articletitle","label":"Article Title"},{"value":"Mathematical Biosciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mbs.2026.109764","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109764"}}